| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | actin filament-based process | MYBPH SHANK1 WASHC2C CALD1 MYOM1 ABI3BP MYO9B PCLO SH3BP1 MYRIP SIRPB1 NPHP4 WASHC2A SHANK3 RYR2 RHPN1 GAS2L1 SSH1 MICALL2 CLN3 COBL AKAP11 MYO18B TNXB | 3.07e-06 | 912 | 188 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYBPH SHANK1 WASHC2C CALD1 MYOM1 ABI3BP PCLO SH3BP1 SIRPB1 NPHP4 WASHC2A SHANK3 RHPN1 GAS2L1 SSH1 MICALL2 CLN3 COBL AKAP11 MYO18B TNXB | 1.47e-05 | 803 | 188 | 21 | GO:0030036 |
| GeneOntologyBiologicalProcess | endocytic recycling | 2.63e-05 | 95 | 188 | 7 | GO:0032456 | |
| GeneOntologyBiologicalProcess | nuclear DNA replication | 6.04e-05 | 46 | 188 | 5 | GO:0033260 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 7.50e-05 | 194 | 188 | 9 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 8.43e-05 | 197 | 188 | 9 | GO:1902904 | |
| GeneOntologyBiologicalProcess | cell cycle DNA replication | 9.97e-05 | 51 | 188 | 5 | GO:0044786 | |
| MousePheno | fetal cardiomyocyte vacuoles | 5.73e-06 | 4 | 159 | 3 | MP:0031614 | |
| Domain | PDZ | SHANK1 DEPTOR MAGIX PCLO FRMPD1 SHANK3 TIAM2 GRIP1 RHPN1 GORASP2 AHNAK MAST1 RAPGEF2 | 4.87e-09 | 151 | 190 | 13 | PS50106 |
| Domain | PDZ | SHANK1 DEPTOR MAGIX PCLO FRMPD1 SHANK3 TIAM2 GRIP1 RHPN1 GORASP2 AHNAK MAST1 RAPGEF2 | 5.28e-09 | 152 | 190 | 13 | IPR001478 |
| Domain | PDZ | SHANK1 DEPTOR MAGIX FRMPD1 SHANK3 TIAM2 GRIP1 RHPN1 GORASP2 AHNAK MAST1 RAPGEF2 | 3.79e-08 | 148 | 190 | 12 | SM00228 |
| Domain | - | SHANK1 DEPTOR MAGIX FRMPD1 SHANK3 TIAM2 GRIP1 RHPN1 GORASP2 AHNAK MAST1 RAPGEF2 | 4.40e-08 | 150 | 190 | 12 | 2.30.42.10 |
| Domain | IG | MYBPH LILRB3 MYOM1 SPEG MPZL1 MXRA8 LILRA6 PAPLN SIRPB1 VSIR IGSF10 PTPRD LRFN5 NCAN ALPK3 CNTN3 MDGA1 SDK1 | 3.20e-07 | 421 | 190 | 18 | SM00409 |
| Domain | Ig_sub | MYBPH LILRB3 MYOM1 SPEG MPZL1 MXRA8 LILRA6 PAPLN SIRPB1 VSIR IGSF10 PTPRD LRFN5 NCAN ALPK3 CNTN3 MDGA1 SDK1 | 3.20e-07 | 421 | 190 | 18 | IPR003599 |
| Domain | IG_LIKE | MYBPH LILRB3 MYOM1 SPEG MPZL1 MXRA8 LILRA6 PAPLN SIRPB1 SLAMF1 VSIR IGSF10 PTPRD LRFN5 NCAN ALPK3 CNTN3 MDGA1 SDK1 | 6.76e-07 | 491 | 190 | 19 | PS50835 |
| Domain | Ig-like_dom | MYBPH LILRB3 MYOM1 SPEG MPZL1 MXRA8 LILRA6 PAPLN SIRPB1 SLAMF1 VSIR IGSF10 PTPRD LRFN5 NCAN ALPK3 CNTN3 MDGA1 SDK1 | 9.70e-07 | 503 | 190 | 19 | IPR007110 |
| Domain | PDZ | SHANK1 MAGIX FRMPD1 SHANK3 TIAM2 GRIP1 RHPN1 AHNAK MAST1 RAPGEF2 | 1.83e-06 | 141 | 190 | 10 | PF00595 |
| Domain | Ig_I-set | MYBPH MYOM1 SPEG PAPLN IGSF10 PTPRD LRFN5 ALPK3 CNTN3 MDGA1 SDK1 | 4.04e-06 | 190 | 190 | 11 | IPR013098 |
| Domain | I-set | MYBPH MYOM1 SPEG PAPLN IGSF10 PTPRD LRFN5 ALPK3 CNTN3 MDGA1 SDK1 | 4.04e-06 | 190 | 190 | 11 | PF07679 |
| Domain | FN3 | MYBPH MYOM1 ABI3BP SPEG PTPRD LRFN5 CNTN3 MDGA1 USH2A TNXB SDK1 | 6.30e-06 | 199 | 190 | 11 | PS50853 |
| Domain | FN3_dom | MYBPH MYOM1 ABI3BP SPEG PTPRD LRFN5 CNTN3 MDGA1 USH2A TNXB SDK1 | 1.00e-05 | 209 | 190 | 11 | IPR003961 |
| Domain | Ig-like_fold | MYBPH LILRB3 MYOM1 ABI3BP SPEG MPZL1 MXRA8 LILRA6 PAPLN SIRPB1 VSIR IGSF10 PTPRD LRFN5 NCAN ALPK3 CNTN3 MDGA1 USH2A TNXB SDK1 | 1.10e-05 | 706 | 190 | 21 | IPR013783 |
| Domain | FN3 | 2.03e-05 | 185 | 190 | 10 | SM00060 | |
| Domain | IGc2 | MYBPH MYOM1 SPEG PAPLN IGSF10 PTPRD LRFN5 ALPK3 CNTN3 MDGA1 SDK1 | 2.99e-05 | 235 | 190 | 11 | SM00408 |
| Domain | Ig_sub2 | MYBPH MYOM1 SPEG PAPLN IGSF10 PTPRD LRFN5 ALPK3 CNTN3 MDGA1 SDK1 | 2.99e-05 | 235 | 190 | 11 | IPR003598 |
| Domain | fn3 | 4.28e-05 | 162 | 190 | 9 | PF00041 | |
| Domain | - | MYBPH MYOM1 ABI3BP SPEG MPZL1 MXRA8 PAPLN SIRPB1 VSIR IGSF10 PTPRD LRFN5 NCAN ALPK3 CNTN3 MDGA1 USH2A TNXB SDK1 | 4.86e-05 | 663 | 190 | 19 | 2.60.40.10 |
| Domain | Znf_piccolo | 1.03e-04 | 2 | 190 | 2 | IPR008899 | |
| Domain | zf-piccolo | 1.03e-04 | 2 | 190 | 2 | PF05715 | |
| Domain | FAM21 | 1.03e-04 | 2 | 190 | 2 | IPR027308 | |
| Domain | CAP-ZIP_m | 3.07e-04 | 3 | 190 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 3.07e-04 | 3 | 190 | 2 | IPR029341 | |
| Domain | Fumarylacetoacetase_C-rel | 6.09e-04 | 4 | 190 | 2 | IPR011234 | |
| Domain | FAA_hydrolase | 6.09e-04 | 4 | 190 | 2 | PF01557 | |
| Domain | - | 6.09e-04 | 4 | 190 | 2 | 3.90.850.10 | |
| Domain | FERM_f0 | 6.09e-04 | 4 | 190 | 2 | PF16511 | |
| Domain | FERM_f0 | 6.09e-04 | 4 | 190 | 2 | IPR032425 | |
| Domain | Znf_FYVE_PHD | 7.76e-04 | 147 | 190 | 7 | IPR011011 | |
| Domain | IGv | 1.00e-03 | 75 | 190 | 5 | SM00406 | |
| Domain | Ig_V-set | 1.00e-03 | 199 | 190 | 8 | IPR013106 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EP400 MYO9B CDK12 POLE SPEG SREBF1 LMTK2 PAPLN CC2D1A NUP214 ZFPM1 NPHP4 WASHC2A DENND1A TIAM2 GGA3 HIVEP3 RHPN1 GAS2L1 TNRC18 C2CD3 WIZ KANSL1 SBF1 SSH1 PLEKHO2 CLN3 AHNAK ANKRD11 NAV1 MAP3K11 COBL RIC8A IRS2 HERC2 WNK2 | 7.55e-18 | 1105 | 192 | 36 | 35748872 |
| Pubmed | WASHC2C EP400 SEPTIN9 SPEG FRMPD1 GON4L NUP214 PHF8 WASHC2A GGA3 MAP7D1 KANSL1 SEC24C UBR5 ZNF451 NAV3 NAV1 MAST1 COBL MTCL1 KIF17 | 1.46e-14 | 407 | 192 | 21 | 12693553 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 RANGAP1 WASHC2C CALD1 EP400 CDK12 SEPTIN9 NACA RBM26 DIDO1 CC2D1A CHD3 NUP214 ADAR EMSY GGA3 KIAA1671 GORASP2 GTF2I FAM193A WIZ AHNAK MKI67 MASTL IRS2 PUS7 | 1.45e-11 | 934 | 192 | 26 | 33916271 |
| Pubmed | SHANK1 RANGAP1 FXR2 APC2 SH3BP1 DIDO1 SIRPB1 SHANK3 EMSY WDR91 MAP7D1 PTPRD WIZ SEC24C SBF1 SSH1 UBR5 NCAN DCHS1 NAV1 MTCL1 EML1 HERC2 RAPGEF2 BSN WNK2 | 2.83e-11 | 963 | 192 | 26 | 28671696 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 RANGAP1 ZNF609 CALD1 EP400 CDK12 SEPTIN9 ZC3H13 RTF2 RBM26 DACH1 ZBTB9 DIDO1 CHD3 NUP214 CBX4 ADAR EMSY GTF2I WIZ AHNAK ZNF451 RECQL5 MKI67 ANKRD11 | 1.31e-10 | 954 | 192 | 25 | 36373674 |
| Pubmed | WASHC2C CDK12 SEPTIN9 ZC3H13 RBM26 ZC3HC1 DIDO1 CC2D1A MCM6 ADAR GORASP2 GTF2I DCP1B MKI67 MASTL MAP3K11 IRS2 MTCL1 | 4.83e-10 | 503 | 192 | 18 | 16964243 | |
| Pubmed | FAHD2B FXR2 APC2 SYT6 FRMPD1 FAHD2A SHANK3 GRIP1 TBC1D10B SBF1 UBR5 NCAN MAST1 MAP3K13 HERC2 RAPGEF2 | 2.67e-09 | 430 | 192 | 16 | 32581705 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | LMTK2 CC2D1A CBX4 LARP1B DENND1A KIAA1671 GRIP1 TBC1D10B MAP7D1 C2CD3 SBF1 DCP1B CASKIN2 AHNAK ANKRD11 NAV1 COBL AKAP11 IRS2 TMEM102 MTCL1 RAPGEF2 | 2.91e-09 | 861 | 192 | 22 | 36931259 |
| Pubmed | ZC3H14 RANGAP1 CALD1 EP400 CDK12 RBM26 DACH1 DIDO1 CC2D1A PHF8 ADAR EMSY GGA3 KIAA1671 GTF2I WIZ AHNAK | 1.28e-08 | 549 | 192 | 17 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANGAP1 WASHC2C EP400 CDK12 SEPTIN9 ZC3H13 DIDO1 CHD3 NUP214 ZFPM1 PHF8 EMSY TBC1D10B GTF2I KANSL1 SEC24C SSH1 CLN3 MKI67 IRS2 | 1.33e-08 | 774 | 192 | 20 | 15302935 |
| Pubmed | ZNF609 ZBTB9 CHD3 E2F6 NUP214 RBBP8NL KIAA1671 MAP7D1 GTF2I FAM193A WIZ UBR5 AHNAK NAV1 IRS2 | 1.38e-08 | 418 | 192 | 15 | 34709266 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZC3H14 RC3H2 RANGAP1 ZNF609 CALD1 FXR2 SEPTIN9 CC2D1A LARP1B WASHC2A ADAR PDIA4 MAP7D1 FAM193A WIZ SBF1 AHNAK MKI67 INO80E | 2.44e-08 | 724 | 192 | 19 | 36232890 |
| Pubmed | ZNF609 IKZF3 EP400 NACA DACH1 ZBTB9 GON4L DIDO1 CC2D1A CHD3 E2F6 NUP214 PHF8 WASHC2A EMSY PDIA4 KIAA1671 MAP7D1 GTF2I WIZ KANSL1 DCP1B ZNF451 RECQL5 MKI67 HERC2 INO80E | 2.58e-08 | 1429 | 192 | 27 | 35140242 | |
| Pubmed | RC3H2 LARP1B WASHC2A KIAA1671 MISP FAM193A DCP1B UBR5 COBL AKAP11 MTCL1 | 2.69e-08 | 209 | 192 | 11 | 36779422 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 RANGAP1 ZNF609 WASHC2C POC1A CALD1 ZNF460 NACA NUP214 WASHC2A PDIA4 MISP MAP7D1 GTF2I CNOT6L KANSL1 MICALL2 UBR5 AHNAK ZNF451 MKI67 MASTL MTCL1 HERC2 | 2.85e-08 | 1155 | 192 | 24 | 20360068 |
| Pubmed | KNTC1 ZNF609 EP400 FXR2 CDK12 NACA MPZL1 MXRA8 RBM26 NUP214 WASHC2A PDIA4 GORASP2 FAM193A CNOT6L DCP1B ZNF451 MASTL NAV1 | 2.97e-08 | 733 | 192 | 19 | 34672954 | |
| Pubmed | ZC3H14 RC3H2 EP400 NACA SREBF1 DIDO1 CC2D1A NUP214 TIAM2 MISP WIZ SEC24C UBR5 FIG4 MKI67 DCHS1 COBL EML1 GALNT5 | 4.62e-08 | 754 | 192 | 19 | 35906200 | |
| Pubmed | ZNF609 EP400 FXR2 ZNF460 ZBTB9 MMP21 CHD3 SIRPB1 CBX4 PHF8 KIAA1671 TRIM66 TBC1D10B MAP7D1 WIZ UBR5 CCNB3 RIC8A IRS2 RAPGEF2 IRX2 WDR72 INO80E | 6.58e-08 | 1116 | 192 | 23 | 31753913 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF609 EP400 ZBTB9 E2F6 NUP214 EMSY PDIA4 KIAA1671 TNRC18 WIZ ASXL3 MKI67 INO80E | 9.12e-08 | 351 | 192 | 13 | 38297188 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | RANGAP1 EP400 NACA DIDO1 MCM6 NUP214 CBX4 ADAR GTF2I WIZ SEC24C UBR5 MKI67 | 1.11e-07 | 357 | 192 | 13 | 37059091 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | RANGAP1 ZNF609 WASHC2C CALD1 EP400 SEPTIN9 RTF2 DACH1 CBX4 EMSY GTF2I AHNAK ZNF451 MASTL | 2.07e-07 | 444 | 192 | 14 | 34795231 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H14 RANGAP1 ZNF609 EP400 ZC3H13 SREBF1 DIDO1 CHD3 E2F6 NUP214 CBX4 PHF8 ADAR EMSY MISP MAP7D1 GTF2I WIZ KANSL1 AHNAK RECQL5 MKI67 ANKRD11 INO80E | 2.31e-07 | 1294 | 192 | 24 | 30804502 |
| Pubmed | RALGDS RANGAP1 ZNF609 EP400 CDK12 NACA LMTK2 DIDO1 TIAM2 GGA3 SBF1 CASKIN2 AKAP11 BSN WNK2 | 2.92e-07 | 529 | 192 | 15 | 14621295 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RANGAP1 EP400 FXR2 RBM26 GON4L DIDO1 MCM6 CHD3 TBC1D10B GTF2I WIZ SEC24C AHNAK | 3.42e-07 | 394 | 192 | 13 | 27248496 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | EP400 FXR2 SEPTIN9 RBM26 ZC3HC1 DIDO1 CHD3 ADAR GTF2I AHNAK MKI67 | 3.70e-07 | 271 | 192 | 11 | 32433965 |
| Pubmed | 4.93e-07 | 222 | 192 | 10 | 37071664 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | EP400 CDK12 RBM26 DACH1 DIDO1 CHD3 ADAR EMSY GTF2I WIZ MKI67 | 5.68e-07 | 283 | 192 | 11 | 30585729 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 7.37e-07 | 232 | 192 | 10 | 25515538 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 DEPTOR CALD1 SEPTIN9 RTF2 MYT1 AFF3 FRMPD1 DMAC2 MYRIP CHD3 RBBP8NL DENND1A KIAA1671 HIVEP3 BMPR1B TNRC18 GTF2I ANKRD11 NAV1 MAST1 ZFHX2 COBL RAPGEF2 WNK2 | 7.96e-07 | 1489 | 192 | 25 | 28611215 |
| Pubmed | ZC3H14 RANGAP1 FXR2 POLE ZC3H13 DIDO1 MCM6 NUP214 PDIA4 GTF2I SEC24C SBF1 UBR5 AHNAK MKI67 HERC2 | 8.07e-07 | 653 | 192 | 16 | 22586326 | |
| Pubmed | KNTC1 ZC3H14 ZNF609 EP400 SEPTIN9 RTF2 RBM26 DACH1 ZBTB9 DIDO1 CC2D1A CHD3 ADAR EMSY PDIA4 TNRC18 MAP7D1 GTF2I WIZ UBR5 MKI67 | 9.18e-07 | 1103 | 192 | 21 | 34189442 | |
| Pubmed | ZC3H14 EP400 CDK12 POLE RTF2 RBM26 GINS4 DIDO1 MCM6 CHD3 CBX4 PHF8 ADAR GTF2I UBR5 AHNAK ZNF451 MKI67 IRX2 PUS7 | 9.89e-07 | 1014 | 192 | 20 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZC3H14 RANGAP1 CALD1 EP400 MYO9B SEPTIN9 NACA MPZL1 MCM6 CHD3 NUP214 ADAR PDIA4 KIAA1671 SEC24C UBR5 AHNAK MKI67 HERC2 MMAB | 1.15e-06 | 1024 | 192 | 20 | 24711643 |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 21940441 | ||
| Pubmed | RANGAP1 ZNF609 MPZL1 LMTK2 TNS2 PHF8 PDIA4 KIAA1671 TBC1D10B GORASP2 C2CD3 PTPRD WIZ SBF1 SSH1 CASKIN2 AHNAK MKI67 HERC2 STX16 | 1.66e-06 | 1049 | 192 | 20 | 27880917 | |
| Pubmed | RC3H2 MYO9B MCL1 CHD3 ADAR TNRC18 SBF1 AHNAK ANKRD11 NAV1 MTCL1 | 2.68e-06 | 332 | 192 | 11 | 37433992 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | WASHC2C SEPTIN9 SYT6 SH3BP1 NUP214 WASHC2A ITIH3 TBC1D10B FAM193A KANSL1 NAV3 HERC2 RAPGEF2 | 2.73e-06 | 475 | 192 | 13 | 31040226 |
| Pubmed | 3.39e-06 | 215 | 192 | 9 | 35973513 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | RANGAP1 EP400 RBM26 DIDO1 CHD3 CBX4 PHF8 EMSY MISP WIZ MKI67 | 3.46e-06 | 341 | 192 | 11 | 32971831 |
| Pubmed | SHANK1 RALGDS ABI3BP NUP214 KANSL1 ZNF451 NAV3 NAV1 MAP3K11 COBL HERC2 RAPGEF2 WNK2 | 3.50e-06 | 486 | 192 | 13 | 20936779 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RANGAP1 CALD1 SEPTIN9 MPZL1 CC2D1A NUP214 GGA3 KIAA1671 TBC1D10B GORASP2 CASKIN2 PLEKHO2 AHNAK CRYBG1 | 3.54e-06 | 565 | 192 | 14 | 25468996 |
| Pubmed | 3.56e-06 | 162 | 192 | 8 | 25826454 | ||
| Pubmed | RALGDS RC3H2 ZNF609 CDK12 POLE NACA SREBF1 GON4L DIDO1 PAPLN CHD3 TBC1D10B MAP7D1 SBF1 CASKIN2 | 3.73e-06 | 650 | 192 | 15 | 38777146 | |
| Pubmed | RANGAP1 ZNF609 EP400 CHD3 NUP214 CBX4 WASHC2A TNRC18 UBR5 AKAP11 | 4.24e-06 | 282 | 192 | 10 | 23667531 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 IKZF3 WASHC2C EP400 MYO9B CBX4 WASHC2A EMSY KIAA1671 UBR5 ZNF451 RECQL5 NAV1 BSN | 5.57e-06 | 588 | 192 | 14 | 38580884 |
| Pubmed | Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells. | 5.70e-06 | 7 | 192 | 3 | 15207857 | |
| Pubmed | CDK12 CHD3 CBX4 VSIR RYR2 GGA3 GRIP1 KANSL1 DCP1B UBR5 ZNF451 HERC2 STX16 SDK1 | 5.90e-06 | 591 | 192 | 14 | 15231748 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANGAP1 EP400 MYO9B SEPTIN9 POLE RTF2 NACA MCM6 NUP214 PHF8 ADAR MAP7D1 GTF2I KANSL1 SEC24C SBF1 UBR5 AHNAK RECQL5 MKI67 RIC8A HERC2 | 6.39e-06 | 1353 | 192 | 22 | 29467282 |
| Pubmed | 6.94e-06 | 83 | 192 | 6 | 28794006 | ||
| Pubmed | EP400 MPZL1 MUC16 ZC3HC1 CC2D1A RYR2 KIAA1671 GORASP2 GTF2I WIZ SEC24C UBR5 AHNAK MKI67 RAPGEF2 SDK1 | 7.40e-06 | 777 | 192 | 16 | 35844135 | |
| Pubmed | RC3H2 EP400 FXR2 CDK12 SEPTIN9 NACA RBM26 DIDO1 CC2D1A CHD3 LARP1B DENND1A ITIH3 TBC1D10B MAP7D1 GTF2I SEC24C AHNAK ZNF451 MKI67 HERC2 INO80E | 7.86e-06 | 1371 | 192 | 22 | 36244648 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 8.35e-06 | 130 | 192 | 7 | 35545047 | |
| Pubmed | ZC3H14 EP400 CDK12 NACA RBM26 GON4L DIDO1 CBX4 DENND1A EMSY KIAA1671 GORASP2 MAP7D1 CNOT6L WIZ SBF1 MICALL2 RECQL5 ANKRD11 CRYBG1 HERC2 STX16 INO80E | 9.72e-06 | 1497 | 192 | 23 | 31527615 | |
| Pubmed | 1.11e-05 | 90 | 192 | 6 | 15033168 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SHANK1 FXR2 MYO9B ZC3H13 PCLO NUP214 ADAR RYR2 C2CD3 FAM193A NAV1 WNK2 | 1.12e-05 | 462 | 192 | 12 | 31138677 |
| Pubmed | 1.36e-05 | 9 | 192 | 3 | 21144999 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.38e-05 | 256 | 192 | 9 | 33397691 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 2.12e-05 | 150 | 192 | 7 | 28242625 | |
| Pubmed | 2.15e-05 | 101 | 192 | 6 | 26949739 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANGAP1 WASHC2C CALD1 FXR2 SEPTIN9 CC2D1A PHF8 WASHC2A EMSY GGA3 KIAA1671 GRIP1 C2CD3 UBR5 COBL HERC2 | 2.32e-05 | 853 | 192 | 16 | 28718761 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 EP400 APC2 NUP214 GGA3 KIAA1671 TNRC18 FAM193A AEBP1 BSN WNK2 | 3.01e-05 | 430 | 192 | 11 | 35044719 |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 3.03e-05 | 2 | 192 | 2 | 23403927 | |
| Pubmed | Essential role of the N-terminal region of TFII-I in viability and behavior. | 3.03e-05 | 2 | 192 | 2 | 20403157 | |
| Pubmed | Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice. | 3.03e-05 | 2 | 192 | 2 | 33402706 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 3.03e-05 | 2 | 192 | 2 | 26793095 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 20332206 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 3.03e-05 | 2 | 192 | 2 | 21935939 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 20827171 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 35358396 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 3.03e-05 | 2 | 192 | 2 | 33526815 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 24339876 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 26229057 | ||
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 3.03e-05 | 2 | 192 | 2 | 36717248 | |
| Pubmed | Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. | 3.03e-05 | 2 | 192 | 2 | 32683896 | |
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 3.03e-05 | 2 | 192 | 2 | 25652077 | |
| Pubmed | A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assembly. | 3.03e-05 | 2 | 192 | 2 | 26524493 | |
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 3.03e-05 | 2 | 192 | 2 | 36449053 | |
| Pubmed | Differential expression of murine CGI-105 gene in 3T3-L1 cells by adrenocorticotropic hormones. | 3.03e-05 | 2 | 192 | 2 | 15774318 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 15847701 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 26823018 | ||
| Pubmed | Structural basis of SALM5-induced PTPδ dimerization for synaptic differentiation. | 3.03e-05 | 2 | 192 | 2 | 29348579 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 19617579 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 29348429 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 27321892 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 32493491 | ||
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 3.03e-05 | 2 | 192 | 2 | 24096970 | |
| Pubmed | 3.51e-05 | 12 | 192 | 3 | 22474384 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 3.56e-05 | 67 | 192 | 5 | 16987237 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | CDK12 ZC3H13 LMTK2 NPHP4 EMSY KIAA1671 MISP MAP7D1 MKI67 NAV1 | 3.57e-05 | 361 | 192 | 10 | 30344098 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYOM1 FXR2 CDK12 ZC3H13 DIDO1 MAP7D1 ASXL3 IRS2 MTCL1 MYO18B | 3.57e-05 | 361 | 192 | 10 | 26167880 |
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 3.67e-05 | 34 | 192 | 4 | 20834067 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | EP400 FXR2 LMTK2 MCM6 NUP214 ADAR GTF2I SBF1 UBR5 MKI67 HERC2 | 3.70e-05 | 440 | 192 | 11 | 34244565 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZBTB9 DIDO1 CHD3 CBX4 PHF8 EMSY GTF2I WIZ ZNF451 RECQL5 MKI67 MASTL HERC2 | 3.71e-05 | 608 | 192 | 13 | 36089195 |
| Pubmed | KNTC1 CALD1 DENND1A KIAA1671 GRIP1 FAM193A UBR5 NAV1 IRS2 MTCL1 RAPGEF2 | 4.19e-05 | 446 | 192 | 11 | 24255178 | |
| Pubmed | 4.94e-05 | 233 | 192 | 8 | 37704626 | ||
| Pubmed | 5.17e-05 | 118 | 192 | 6 | 30979931 | ||
| Pubmed | 5.76e-05 | 14 | 192 | 3 | 16452088 | ||
| Pubmed | RC3H2 RANGAP1 NACA RBM26 GON4L MCM6 ADAR MAP7D1 WIZ SSH1 UBR5 AHNAK | 5.80e-05 | 547 | 192 | 12 | 37267103 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | MYO9B CDK12 MUC16 ZC3HC1 FAM193A ASXL3 AHNAK ZFHX2 CRYBG1 AKAP11 HERC2 TNXB | 6.33e-05 | 552 | 192 | 12 | 10737800 |
| Pubmed | 6.44e-05 | 242 | 192 | 8 | 34011540 | ||
| Interaction | TOP3B interactions | RC3H2 POC1A EP400 FXR2 MYO9B CDK12 POLE SPEG SREBF1 LMTK2 PAPLN CC2D1A NUP214 ZFPM1 NPHP4 WASHC2A DENND1A TIAM2 GGA3 HIVEP3 RHPN1 GAS2L1 GORASP2 TNRC18 C2CD3 GTF2I CNOT6L WIZ KANSL1 SBF1 SSH1 PLEKHO2 CLN3 AHNAK RECQL5 ANKRD11 NAV1 MAP3K11 COBL RIC8A IRS2 HERC2 WNK2 | 1.72e-11 | 1470 | 190 | 43 | int:TOP3B |
| Interaction | YWHAH interactions | ZC3H14 FXR2 SPEG ZC3H13 LMTK2 TNS2 CC2D1A CBX4 LARP1B DENND1A PDIA4 KIAA1671 GRIP1 TBC1D10B MAP7D1 C2CD3 SBF1 SSH1 DCP1B CASKIN2 AHNAK ANKRD11 NAV1 MAST1 COBL AKAP11 IRS2 TMEM102 MTCL1 RAPGEF2 WNK2 | 4.46e-08 | 1102 | 190 | 31 | int:YWHAH |
| Interaction | GSK3A interactions | ZC3H14 RC3H2 FXR2 SGK1 MCL1 LARP1B WASHC2A KIAA1671 MISP TNRC18 FAM193A DCP1B UBR5 MAP3K11 COBL CRYBG1 AKAP11 MTCL1 | 4.43e-07 | 464 | 190 | 18 | int:GSK3A |
| Interaction | NUP43 interactions | RANGAP1 ZNF609 EP400 CDK12 ZC3H13 RBM26 ZBTB9 GON4L CHD3 E2F6 NUP214 PHF8 EMSY RYR2 GTF2I KANSL1 UBR5 RECQL5 MKI67 ANKRD11 RAPGEF2 | 4.99e-07 | 625 | 190 | 21 | int:NUP43 |
| Interaction | SLX4 interactions | RANGAP1 EP400 NACA AFF3 RBM26 ZBTB9 DIDO1 MCM6 NUP214 CBX4 PHF8 ADAR EMSY GTF2I WIZ SEC24C UBR5 ZNF451 RECQL5 MKI67 | 5.11e-07 | 572 | 190 | 20 | int:SLX4 |
| Interaction | GSK3B interactions | BHLHE41 RC3H2 SGK1 SEPTIN9 NACA SREBF1 MCL1 MCM6 CHD3 ZFPM1 LARP1B WASHC2A SHANK3 PDIA4 KIAA1671 MISP FAM193A DCP1B UBR5 MKI67 MAP3K11 COBL AKAP11 MTCL1 HERC2 | 6.78e-07 | 868 | 190 | 25 | int:GSK3B |
| Interaction | NAA40 interactions | ZC3H14 RANGAP1 WASHC2C CALD1 EP400 CDK12 SEPTIN9 NACA RBM26 DIDO1 CC2D1A CHD3 NUP214 ADAR EMSY GGA3 KIAA1671 GORASP2 GTF2I FAM193A WIZ AHNAK MKI67 MASTL IRS2 PUS7 | 1.78e-06 | 978 | 190 | 26 | int:NAA40 |
| Interaction | CAPZA2 interactions | RC3H2 WASHC2C CALD1 SH3BP1 WASHC2A SHANK3 KIAA1671 GAS2L1 MISP CNOT6L PLEKHO2 ASXL3 AHNAK COBL CRYBG1 MTCL1 | 3.39e-06 | 430 | 190 | 16 | int:CAPZA2 |
| Interaction | FBXW11 interactions | BHLHE41 DEPTOR POLE NACA MCL1 TNS2 ADAR GTF2I WIZ SBF1 SSH1 UBR5 NAV1 COBL IRS2 RAPGEF2 | 1.12e-05 | 473 | 190 | 16 | int:FBXW11 |
| Interaction | YWHAG interactions | RC3H2 CDK12 SPEG ZC3H13 LMTK2 TNS2 CBX4 LARP1B DENND1A SHANK3 PDIA4 KIAA1671 GRIP1 TBC1D10B MAP7D1 C2CD3 SBF1 SSH1 DCP1B CASKIN2 ANKRD11 NAV1 COBL AKAP11 IRS2 TMEM102 MTCL1 RAPGEF2 | 1.71e-05 | 1248 | 190 | 28 | int:YWHAG |
| Interaction | SMC5 interactions | ZC3H14 RANGAP1 ZNF609 CALD1 EP400 CDK12 SEPTIN9 ZC3H13 RTF2 RBM26 DACH1 ZBTB9 DIDO1 CHD3 NUP214 CBX4 ADAR EMSY GTF2I WIZ AHNAK RECQL5 MKI67 ANKRD11 | 2.50e-05 | 1000 | 190 | 24 | int:SMC5 |
| Interaction | PNMA2 interactions | 2.75e-05 | 251 | 190 | 11 | int:PNMA2 | |
| Interaction | MYB interactions | 3.86e-05 | 133 | 190 | 8 | int:MYB | |
| Interaction | HDAC1 interactions | BHLHE41 ZNF609 IKZF3 EP400 MYT1 SREBF1 DACH1 ZBTB9 GON4L CHD3 E2F6 NUP214 ZFPM1 EMSY KIAA1671 GRIP1 TNRC18 MAP7D1 GTF2I WIZ UBR5 AHNAK MKI67 NAV1 IRS2 | 4.62e-05 | 1108 | 190 | 25 | int:HDAC1 |
| Interaction | HNF4A interactions | ZNF609 EP400 SREBF1 DACH1 ZBTB9 CHD3 E2F6 EMSY WIZ KANSL1 ZNF451 | 6.30e-05 | 275 | 190 | 11 | int:HNF4A |
| Interaction | TERF2IP interactions | ZC3H14 ZNF609 EP400 CDK12 OGFR DACH1 DIDO1 CHD3 EMSY GTF2I WIZ RECQL5 MKI67 ANKRD11 MASTL PUS7 | 7.23e-05 | 552 | 190 | 16 | int:TERF2IP |
| Interaction | SLC6A4 interactions | FXR2 APC2 SYT6 FRMPD1 SHANK3 GRIP1 TBC1D10B SBF1 UBR5 NCAN MAST1 MAP3K13 HERC2 RAPGEF2 | 7.24e-05 | 437 | 190 | 14 | int:SLC6A4 |
| Interaction | PIN1 interactions | IKZF3 CDK12 SGK1 SEPTIN9 MYT1 ZBTB9 MCL1 TNS2 DIDO1 RBBP8NL WIZ MAP3K11 INO80E | 7.39e-05 | 383 | 190 | 13 | int:PIN1 |
| Interaction | KDM1A interactions | ZNF609 IKZF3 EP400 MYT1 ZBTB9 CHD3 E2F6 NUP214 ZFPM1 PHF8 RBBP8NL KIAA1671 MAP7D1 GTF2I FAM193A WIZ KANSL1 UBR5 AHNAK ZNF451 NAV1 IRS2 | 8.19e-05 | 941 | 190 | 22 | int:KDM1A |
| Interaction | YY1 interactions | EP400 SREBF1 ZBTB9 GON4L DIDO1 CHD3 CBX4 ZNF232 EMSY GTF2I WIZ KANSL1 MKI67 INO80E | 1.08e-04 | 454 | 190 | 14 | int:YY1 |
| Interaction | CPEB4 interactions | 1.19e-04 | 156 | 190 | 8 | int:CPEB4 | |
| GeneFamily | PDZ domain containing | SHANK1 DEPTOR MAGIX PCLO FRMPD1 SHANK3 TIAM2 GRIP1 RHPN1 GORASP2 AHNAK MAST1 RAPGEF2 | 8.52e-11 | 152 | 132 | 13 | 1220 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | MYBPH MYOM1 SPEG PAPLN IGSF10 PTPRD LRFN5 ALPK3 CNTN3 MDGA1 SDK1 | 2.71e-08 | 161 | 132 | 11 | 593 |
| GeneFamily | Fibronectin type III domain containing | 2.66e-06 | 160 | 132 | 9 | 555 | |
| GeneFamily | Zinc fingers CCCH-type | 1.19e-04 | 35 | 132 | 4 | 73 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.62e-04 | 15 | 132 | 3 | 26 | |
| GeneFamily | WASH complex | 7.78e-04 | 6 | 132 | 2 | 1331 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.44e-03 | 8 | 132 | 2 | 658 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.28e-03 | 36 | 132 | 3 | 823 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RALGDS IKZF3 SPEG PCLO MYT1 APC2 AFF3 SYT6 RBM26 CHD3 CBX4 LARP1B SHANK3 RYR2 GRIP1 HIVEP3 CNOT6L LRFN5 ASXL3 NCAN DACT3 NAV3 NAV1 MAST1 ZFHX2 BSN MDGA1 IRX2 | 1.07e-08 | 1106 | 192 | 28 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | SPEG MYT1 APC2 LARP1B RYR2 GRIP1 HIVEP3 ASXL3 NCAN DACT3 NAV1 MAST1 ZFHX2 BSN MDGA1 IRX2 USH2A | 6.59e-08 | 465 | 192 | 17 | M39066 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | RC3H2 RANGAP1 CALD1 SEPTIN9 ZC3H13 AFF3 GON4L CBX4 PDIA4 MAP7D1 PTPRD KANSL1 SSH1 AHNAK NAV1 | 2.02e-06 | 467 | 192 | 15 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | RC3H2 RANGAP1 CALD1 SEPTIN9 ZC3H13 AFF3 GON4L CBX4 PDIA4 MAP7D1 PTPRD KANSL1 SSH1 AHNAK NAV1 | 3.12e-06 | 484 | 192 | 15 | MM999 |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP | 1.64e-05 | 198 | 192 | 9 | M5170 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | KNTC1 RANGAP1 POC1A MYO9B SGK1 POLE PCLO SREBF1 GINS4 MCM6 GAS2L1 MAP7D1 MKI67 MASTL PIF1 | 2.04e-05 | 567 | 192 | 15 | M45692 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.90e-05 | 221 | 192 | 9 | M39222 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ABI3BP AFF3 SYT6 DACH1 IGSF10 PTPRD HECTD2 LRFN5 ASXL3 CNTN3 LRRC17 | 1.05e-09 | 197 | 192 | 11 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-09 | 180 | 192 | 10 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.83e-09 | 186 | 192 | 10 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-08 | 189 | 192 | 10 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-08 | 189 | 192 | 10 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-08 | 192 | 192 | 10 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-08 | 192 | 192 | 10 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-08 | 194 | 192 | 10 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-08 | 194 | 192 | 10 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.71e-08 | 181 | 192 | 9 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-07 | 188 | 192 | 9 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-07 | 190 | 192 | 9 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-07 | 191 | 192 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.75e-07 | 194 | 192 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-07 | 196 | 192 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.91e-07 | 196 | 192 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-07 | 197 | 192 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.00e-07 | 197 | 192 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-07 | 198 | 192 | 9 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.08e-07 | 198 | 192 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-07 | 198 | 192 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.17e-07 | 199 | 192 | 9 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-07 | 200 | 192 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-07 | 200 | 192 | 9 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-07 | 200 | 192 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-07 | 200 | 192 | 9 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-07 | 171 | 192 | 8 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.19e-06 | 180 | 192 | 8 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 180 | 192 | 8 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-06 | 184 | 192 | 8 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 184 | 192 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 184 | 192 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 184 | 192 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-06 | 185 | 192 | 8 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.46e-06 | 185 | 192 | 8 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.46e-06 | 185 | 192 | 8 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-06 | 186 | 192 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-06 | 186 | 192 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-06 | 186 | 192 | 8 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.58e-06 | 187 | 192 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.64e-06 | 188 | 192 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 188 | 192 | 8 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-06 | 188 | 192 | 8 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 188 | 192 | 8 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 189 | 192 | 8 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 189 | 192 | 8 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.78e-06 | 190 | 192 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.78e-06 | 190 | 192 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.78e-06 | 190 | 192 | 8 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 192 | 192 | 8 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 192 | 192 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-06 | 192 | 192 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 192 | 192 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.92e-06 | 192 | 192 | 8 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 193 | 192 | 8 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.00e-06 | 193 | 192 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.00e-06 | 193 | 192 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 194 | 192 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 194 | 192 | 8 | c2990d6eda3954dc01913bf3910df79f06e0010a | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 194 | 192 | 8 | 20a0439fa02c5f8107612e34c7ab54120b9b8573 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 194 | 192 | 8 | 0e315c63407fa00643722a7d6138b1502f79b10d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 194 | 192 | 8 | 588c45dafa00547b2506e298a2434b1b5e15560d | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 195 | 192 | 8 | 613bea20c3d82c22a6af4c1a668af6fcf11fec0a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.16e-06 | 195 | 192 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 196 | 192 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.24e-06 | 196 | 192 | 8 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.24e-06 | 196 | 192 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 196 | 192 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 196 | 192 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 196 | 192 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.33e-06 | 197 | 192 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-06 | 197 | 192 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-06 | 197 | 192 | 8 | d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.42e-06 | 198 | 192 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.42e-06 | 198 | 192 | 8 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.42e-06 | 198 | 192 | 8 | c7075dce915ab8387309fcb12c5f6a17d4100cda | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.42e-06 | 198 | 192 | 8 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.51e-06 | 199 | 192 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 199 | 192 | 8 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 199 | 192 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 199 | 192 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 199 | 192 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.51e-06 | 199 | 192 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.51e-06 | 199 | 192 | 8 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 199 | 192 | 8 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 199 | 192 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 192 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.60e-06 | 200 | 192 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 200 | 192 | 8 | 6fa339666c4032b29ac521e88f0e917a57013cde | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.60e-06 | 200 | 192 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 192 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 192 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.60e-06 | 200 | 192 | 8 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 2.60e-06 | 200 | 192 | 8 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 192 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 192 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 192 | 8 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 192 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | proximal-3-mesenchymal-Airway_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 200 | 192 | 8 | e9a008bfe336002218c63d1c2231986e1b237621 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 200 | 192 | 8 | 5eeb8eb3fe74f5a8055c52ec77e38237bb63ed90 | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 6.16e-06 | 197 | 189 | 10 | 5211_DN | |
| Drug | rapamycin; Down 200; 0.1uM; ssMCF7; HG-U133A | 6.74e-06 | 199 | 189 | 10 | 402_DN | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.64e-05 | 186 | 189 | 9 | 5777_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | BHLHE41 MYO9B SEPTIN9 ZC3H13 MPZL1 DACH1 GINS4 MICALL2 RECQL5 | 3.53e-05 | 193 | 189 | 9 | 5256_DN |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 3.68e-05 | 194 | 189 | 9 | 4249_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 3.68e-05 | 194 | 189 | 9 | 1699_DN | |
| Drug | Methamphetamine | KNTC1 ZNF609 WASHC2C MYOM1 EP400 SGK1 SPEG MYT1 GON4L MCL1 TNS2 SLC35B2 EMSY PDIA4 TH FAM193A CNOT6L SBF1 AHNAK MKI67 ANKRD11 MASTL HERC2 MYO18B USPL1 USH2A KIF17 | 3.81e-05 | 1401 | 189 | 27 | ctd:D008694 |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.83e-05 | 195 | 189 | 9 | 3408_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; PC3; HT_HG-U133A | 4.15e-05 | 197 | 189 | 9 | 6666_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.15e-05 | 197 | 189 | 9 | 4974_DN | |
| Drug | Ginkgolide A [15291-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 4.31e-05 | 198 | 189 | 9 | 3260_DN | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.31e-05 | 198 | 189 | 9 | 2882_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 199 | 189 | 9 | 3224_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 4.49e-05 | 199 | 189 | 9 | 5787_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | 4.49e-05 | 199 | 189 | 9 | 6287_UP | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.49e-05 | 199 | 189 | 9 | 5804_DN | |
| Disease | QRS-T angle | 5.68e-05 | 106 | 185 | 6 | EFO_0020097 | |
| Disease | platelet crit | BHLHE41 DEPTOR MYO9B AFF3 DACH1 ZC3HC1 SIRPB1 ZFPM1 KANSL1 PLEKHO2 CLN3 NCAN NAV3 DCHS1 IRS2 TM2D1 PIF1 | 1.11e-04 | 952 | 185 | 17 | EFO_0007985 |
| Disease | Catecholaminergic polymorphic ventricular tachycardia 1 | 1.17e-04 | 3 | 185 | 2 | cv:C1631597 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY | 1.17e-04 | 3 | 185 | 2 | 604772 | |
| Disease | Autism Spectrum Disorders | 2.01e-04 | 85 | 185 | 5 | C1510586 | |
| Disease | skin pigmentation measurement | 2.33e-04 | 137 | 185 | 6 | EFO_0007009 | |
| Disease | cognitive inhibition measurement | 2.75e-04 | 50 | 185 | 4 | EFO_0007969 | |
| Disease | Metastatic melanoma | 3.70e-04 | 54 | 185 | 4 | C0278883 | |
| Disease | unipolar depression, bipolar disorder | 4.67e-04 | 156 | 185 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | cardiac troponin T measurement | 4.85e-04 | 219 | 185 | 7 | EFO_0005043 | |
| Disease | Hypermetropia | 4.89e-04 | 103 | 185 | 5 | HP_0000540 | |
| Disease | osteonecrosis | 5.04e-04 | 25 | 185 | 3 | EFO_0004259 | |
| Disease | Dwarfism | 5.04e-04 | 25 | 185 | 3 | C0013336 | |
| Disease | Intellectual Disability | 5.54e-04 | 447 | 185 | 10 | C3714756 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 5.77e-04 | 6 | 185 | 2 | EFO_0802705 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 5.77e-04 | 6 | 185 | 2 | EFO_0801767 | |
| Disease | body surface area | KNTC1 MYO9B DMAC2 ZBTB9 MCL1 DIDO1 TIAM2 TRIM66 MAP7D1 MICALL2 ANKRD11 PRKG2 | 7.92e-04 | 643 | 185 | 12 | EFO_0022196 |
| Disease | grapefruit juice consumption measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0010094 | |
| Disease | basophil count, eosinophil count | 8.52e-04 | 241 | 185 | 7 | EFO_0004842, EFO_0005090 | |
| Disease | self rated health | 9.58e-04 | 31 | 185 | 3 | EFO_0004778 | |
| Disease | Large cell carcinoma of lung | 1.05e-03 | 32 | 185 | 3 | C0345958 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.17e-03 | 125 | 185 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.17e-03 | 125 | 185 | 5 | C1879321 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.28e-03 | 75 | 185 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Unipolar Depression | 1.29e-03 | 259 | 185 | 7 | C0041696 | |
| Disease | Antihypertensive use measurement | 1.47e-03 | 265 | 185 | 7 | EFO_0009927 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.70e-03 | 10 | 185 | 2 | C1631597 | |
| Disease | Profound Mental Retardation | 1.87e-03 | 139 | 185 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.87e-03 | 139 | 185 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.87e-03 | 139 | 185 | 5 | C0917816 | |
| Disease | mean platelet volume | MYO9B CDK12 NACA AFF3 SIRPB1 IRAG1 SHANK3 GORASP2 SSH1 PLEKHO2 CLN3 ANKRD11 MAP3K11 IRS2 MMAB | 2.01e-03 | 1020 | 185 | 15 | EFO_0004584 |
| Disease | insomnia measurement | 2.02e-03 | 443 | 185 | 9 | EFO_0007876 | |
| Disease | stomach cancer (is_marker_for) | 2.06e-03 | 142 | 185 | 5 | DOID:10534 (is_marker_for) | |
| Disease | atopic eczema, childhood onset asthma, atopic march | 2.07e-03 | 11 | 185 | 2 | EFO_0000274, EFO_0007755, MONDO_0005405 | |
| Disease | phosphatidylcholine 32:0 measurement | 2.07e-03 | 11 | 185 | 2 | EFO_0010372 | |
| Disease | Umbilical hernia | 2.07e-03 | 11 | 185 | 2 | HP_0001537 | |
| Disease | QRS duration | 2.85e-03 | 298 | 185 | 7 | EFO_0005055 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.91e-03 | 13 | 185 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | illegal drug consumption | 2.91e-03 | 13 | 185 | 2 | EFO_0005431 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.91e-03 | 13 | 185 | 2 | cv:C4082197 | |
| Disease | age at menopause | 3.07e-03 | 302 | 185 | 7 | EFO_0004704 | |
| Disease | Adenocarcinoma of large intestine | 3.17e-03 | 96 | 185 | 4 | C1319315 | |
| Disease | diastolic blood pressure, systolic blood pressure | POC1A CALD1 SPEG DMAC2 MCL1 RBBP8NL RYR2 KIAA1671 C2CD3 NAV1 PIF1 | 3.50e-03 | 670 | 185 | 11 | EFO_0006335, EFO_0006336 |
| Disease | coronary artery disease | MYO9B CDK12 SREBF1 MCL1 ZC3HC1 ZFPM1 IRAG1 IGSF10 BMPR1B GPR149 EML1 RAPGEF2 BSN TNXB WNK2 WDR72 | 3.61e-03 | 1194 | 185 | 16 | EFO_0001645 |
| Disease | restless legs syndrome | 3.61e-03 | 49 | 185 | 3 | EFO_0004270 | |
| Disease | corpus callosum volume measurement | 3.67e-03 | 100 | 185 | 4 | EFO_0010299 | |
| Disease | squamous cell lung carcinoma | 3.92e-03 | 165 | 185 | 5 | EFO_0000708 | |
| Disease | monocyte count | LILRB3 FXR2 LILRA6 GON4L MCL1 DIDO1 MCM6 SIRPB1 ZFPM1 IRAG1 MEI1 VSIR HIVEP3 WDR91 MAST1 IRS2 TM2D1 | 4.05e-03 | 1320 | 185 | 17 | EFO_0005091 |
| Disease | forced expiratory volume | CDK12 SEPTIN9 AFF3 MCL1 RYR2 KANSL1 SEC24C FIG4 PLEKHO2 AHNAK MTCL1 TNXB | 4.29e-03 | 789 | 185 | 12 | EFO_0004314 |
| Disease | Schizoaffective disorder-bipolar type | 4.43e-03 | 16 | 185 | 2 | EFO_0009965 | |
| Disease | Major Depressive Disorder | 4.43e-03 | 243 | 185 | 6 | C1269683 | |
| Disease | Leukemia, Myelocytic, Acute | 4.79e-03 | 173 | 185 | 5 | C0023467 | |
| Disease | hematocrit | CALD1 AFF3 SREBF1 ZC3HC1 CHD3 ZFPM1 RBBP8NL IRAG1 TH BMPR1B MICALL2 IRS2 BSN STX16 | 4.80e-03 | 1011 | 185 | 14 | EFO_0004348 |
| Disease | obsolete_red blood cell distribution width | RALGDS EP400 FXR2 MYO9B CDK12 ZC3HC1 PAPLN MCM6 ZFPM1 VSIR GTF2I KANSL1 FIG4 MAST1 CRYBG1 IRS2 MMAB | 4.95e-03 | 1347 | 185 | 17 | EFO_0005192 |
| Disease | alkaline phosphatase measurement | RALGDS TMEM176B CALD1 PAPLN CHD3 ZFPM1 LARP1B ITIH3 HIVEP3 WDR91 GORASP2 KANSL1 AHNAK KIF17 | 4.96e-03 | 1015 | 185 | 14 | EFO_0004533 |
| Disease | Benign neoplasm of stomach | 5.00e-03 | 17 | 185 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.00e-03 | 17 | 185 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 5.00e-03 | 17 | 185 | 2 | C0154060 | |
| Disease | vital capacity | KNTC1 CDK12 SEPTIN9 PCLO MYT1 AFF3 FRMPD1 MCL1 RYR2 TIAM2 TRIM66 PTPRD KANSL1 MTCL1 MYO18B TNXB | 5.01e-03 | 1236 | 185 | 16 | EFO_0004312 |
| Disease | alcohol consumption measurement | RC3H2 CDK12 PCLO AFF3 PAPLN DENND1A GRIP1 TRIM66 KANSL1 LRFN5 CLN3 ANKRD11 COBL AKAP11 MMAB SDK1 | 5.24e-03 | 1242 | 185 | 16 | EFO_0007878 |
| Disease | multiple myeloma | 5.49e-03 | 112 | 185 | 4 | EFO_0001378 | |
| Disease | idiopathic pulmonary fibrosis | 5.53e-03 | 57 | 185 | 3 | EFO_0000768 | |
| Disease | Hypertrophic Cardiomyopathy | 5.53e-03 | 57 | 185 | 3 | C0007194 | |
| Disease | immature platelet fraction | 5.84e-03 | 114 | 185 | 4 | EFO_0009187 | |
| Disease | eosinophil count | IKZF3 MYT1 SREBF1 ZBTB9 MCL1 ZC3HC1 ZFPM1 SLAMF1 EMSY TG HIVEP3 FAM193A KANSL1 PLEKHO2 ANKRD11 MAP3K11 MMAB TNXB | 5.94e-03 | 1488 | 185 | 18 | EFO_0004842 |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 6.09e-03 | 59 | 185 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | Alzheimer disease, age at onset | 6.10e-03 | 343 | 185 | 7 | EFO_0004847, MONDO_0004975 | |
| Disease | skin sensitivity to sun | 6.23e-03 | 19 | 185 | 2 | EFO_0004795 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 6.23e-03 | 19 | 185 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADALGTSVVVPPEPT | 611 | P51826 | |
| PRAVGSPATATPDLV | 2681 | Q96L91 | |
| RQSGVVVEEPPPSKT | 1051 | Q9NYV4 | |
| LEVSFTEPPGDDKPR | 1321 | Q6UB99 | |
| SRVTIKQEPPGEDSP | 261 | Q9C0J9 | |
| SGKRPPILAPSETLE | 166 | Q8IUX7 | |
| ATEEGVNRIAVPKPP | 16 | Q96GX5 | |
| RKPVSIVSPEPGTTR | 271 | Q969Y2 | |
| KVTRSPPETAAPVED | 546 | Q9Y3L3 | |
| PGPSSLTVPAIVVDE | 1266 | Q96L96 | |
| PEVDVRGPKVDVSAP | 601 | Q09666 | |
| PDSPRPVKASREDSG | 431 | Q9UKA4 | |
| ASASSREGLPEAPKP | 46 | Q5T7M4 | |
| KSGPEEQPRDTASPV | 241 | Q9NW81 | |
| EDGESTAPTPRPKVL | 16 | O00238 | |
| TSVIKERVPDSPSPA | 481 | Q9UI36 | |
| RRPTEPPKATEGQSK | 1061 | P78312 | |
| SVGKTAPERNVEIPP | 1786 | Q9C0F0 | |
| PQAKGTPKEITPRED | 1101 | Q8WWL7 | |
| RTKEEDPIIPFSDGP | 886 | Q9HBD1 | |
| SRKILDPNTGEPAPV | 411 | P46060 | |
| VKERLGPVPSSTIEP | 636 | Q5T8P6 | |
| PKEPSLGEQSRLVPA | 316 | Q9Y4B5 | |
| RPPDSVTEGPTSKRA | 681 | Q96NI6 | |
| ETVPPTISVPKGRAV | 436 | Q8NFP4 | |
| KDVSHLRPEPPDTGV | 481 | Q5HY64 | |
| ETGVSRLHPEPPKTR | 696 | Q5HY64 | |
| SVESPGTPKETPIER | 281 | Q8IVT2 | |
| STVPPDTFTGEIPRV | 5241 | Q8WXI7 | |
| GDVPRPSSLPVEETS | 7376 | Q8WXI7 | |
| TEAGSAVPTVLPEVP | 10971 | Q8WXI7 | |
| EPSARVDISIVPGTP | 771 | Q96JQ0 | |
| DHGEVTKVPRPPATL | 306 | Q8NBT0 | |
| VPDVSKLSTPGARAE | 251 | Q14566 | |
| GKPEEESPSTLLRPS | 271 | A8MTJ6 | |
| TLKKTRGSPEPSPEA | 261 | Q9H6Y5 | |
| PPTAKAPTTVEDRVG | 416 | Q9H8Y8 | |
| VSGSRPEVAAKPALP | 171 | Q9BY89 | |
| LHKRPEVDSPGETPS | 1736 | Q9BY89 | |
| PPLERTKPSEDSLSG | 626 | P51116 | |
| RVTKPEPAALPGLDT | 746 | O95714 | |
| VSGRPPVIKPEVDST | 226 | Q8N6Y2 | |
| ATPLVVAAPAPEERK | 11 | Q5U5R9 | |
| RAEPATPVVKAVPEA | 641 | Q9UPA5 | |
| AREEPLPTTTPAAIK | 2306 | Q9UPA5 | |
| SPASLSEPRKVSPEG | 346 | Q5VYM1 | |
| RSLPGSAPPLTEKEV | 511 | Q9Y6F6 | |
| RPSESRLAPTPTEGK | 321 | Q8IY33 | |
| SVVPKPEGPVADTVS | 2276 | Q9Y6V0 | |
| SEIIESVPPAGPEAS | 6 | Q9HCI6 | |
| PPETPKGAALAEAVR | 76 | Q8N119 | |
| PSSDRLKPPVSEGVK | 361 | Q8IVL0 | |
| GSSEPPAAPRSIKVE | 451 | Q8IX07 | |
| APARVKAELSSPTPG | 496 | Q8IX07 | |
| KTGRETEAAPTSPPI | 1071 | Q7Z3B3 | |
| TTGVPDARTEAVPPA | 1571 | P35658 | |
| KPGSTPEPIAAEVRS | 1031 | P50748 | |
| SEPEKRSEEVPGTSP | 1111 | Q8IWU2 | |
| TGVAPALAPKVEPAV | 486 | Q9NZ52 | |
| PLGPALVTKDSVADP | 216 | Q96GK7 | |
| SDPLEILPSGVSRKP | 211 | Q6PI73 | |
| SDPLEILPSGVSRKP | 211 | O75022 | |
| SRKPEGSPVTERAIP | 1081 | Q07864 | |
| PKVEPVGDVVSTRDP | 2966 | P46013 | |
| PVKQAPRKSPSDTEG | 211 | O95297 | |
| GETEPPAAPAALLKV | 1081 | Q8WXE0 | |
| EEGERGLAPPKPVTS | 271 | Q9BZI1 | |
| GSPLQASPDKVPLEV | 91 | Q13237 | |
| PKTPVAAAGSSKREP | 726 | Q9Y2H9 | |
| PRDIFLKVASGPSPE | 1191 | O75161 | |
| TEGTPKLSDTPAPKR | 81 | Q8NBZ0 | |
| PEKTGPPSKEELSAV | 641 | Q5TIA1 | |
| AVKAERRTTVPSGPP | 531 | O95248 | |
| TPPTAGRVVSLSPED | 241 | Q86SP6 | |
| PSAEPVGRSPDLSKS | 746 | O43283 | |
| PKPEAARVASPTSGV | 1091 | Q9Y4H2 | |
| PVAKISPGATLPESR | 191 | Q8NC74 | |
| GHPEPSKAEVLRPES | 556 | Q8NC74 | |
| AQPTSVPPKERESGL | 531 | Q8IZD4 | |
| PPPRKTSDAVVQTEE | 2181 | O95996 | |
| PITFPKADIARVPSE | 1086 | Q6WRI0 | |
| EPLVRAPDKGTDSPS | 2006 | Q4AC94 | |
| ERPKSLGDASPSAPE | 161 | Q96B18 | |
| AVKAPAETRLDVPAP | 201 | O75461 | |
| SVPETAPAAIPETKR | 371 | P55265 | |
| PLGPALVTKDSVADP | 216 | Q6P2I3 | |
| VGIDPSPFTVRKPDE | 706 | Q92562 | |
| ATPAPSEKGEGIRTP | 1556 | Q12873 | |
| TPVSLRSTKEGPETP | 321 | Q99501 | |
| TVSPAVPPEGIKAEA | 1216 | Q5SYB0 | |
| IDVTLSPRDPKAPGQ | 426 | Q7Z7M9 | |
| PVLAAPPVTVKDDRT | 901 | O75128 | |
| KRPVTSEELLTPGAP | 311 | Q8TB45 | |
| EVRLSSPPGKPEDSS | 1421 | Q3T8J9 | |
| PEVETSRTPPGESIK | 1566 | Q3T8J9 | |
| SETEKLPGTVEPPAS | 2036 | Q3T8J9 | |
| RSEAGEPPSSLQVKP | 481 | O00257 | |
| LGEEQKASETPPPVA | 111 | Q6P1N0 | |
| APEPRVTLEGPSATA | 221 | Q6P1N0 | |
| SVERPAEPVAGAATP | 1456 | Q9BTC0 | |
| PSPVVAENGLSEEKP | 366 | Q12967 | |
| SSPEPVKAVEARSPG | 741 | Q3KQU3 | |
| LNPSDKEEVPTPTLG | 681 | Q8TEH3 | |
| GPATQKRESPPAEIL | 101 | Q8NEG0 | |
| PTEAKPISPTTREAA | 491 | A8MUX0 | |
| EETTASTLRGKPRPP | 6 | A4QMS7 | |
| LTTRKIDPPAVPATG | 1221 | Q7Z589 | |
| STARPKIISPVSGPE | 321 | Q902F9 | |
| LPSPSGVRKETAVPA | 111 | O00423 | |
| PKARPTILSSGLPEE | 196 | Q5T9C2 | |
| RVPDPSPVTKGTAAE | 136 | Q9Y4K1 | |
| PPLSTERSPEAVGSE | 526 | Q9Y4K1 | |
| RKPASSEPTPEDALG | 31 | Q9Y5M1 | |
| PSSRKPGDPLVISDI | 591 | Q9Y3R0 | |
| RPRSPGSNSKVPEIE | 671 | P78347 | |
| LPEKSVPSERGLSPN | 366 | Q9UKT9 | |
| KSPVESTTEPPAVRA | 956 | P53992 | |
| ATVITTEKRERPAPP | 1466 | Q7Z5N4 | |
| IKIAEDPSRDGPSPN | 2351 | Q92736 | |
| PSLPSEKVRTEEAVP | 686 | Q9P232 | |
| EEPKRPVPAERGSSS | 621 | Q16584 | |
| TVVAPSAVAGKRPPE | 36 | Q9NX14 | |
| PAPVKLRESVSVPEG | 381 | Q659C4 | |
| PIGAEVPDVTATPAR | 81 | Q07820 | |
| EDGDRPQPSSKTPRI | 41 | Q96EY8 | |
| TNEDVPSGPPRKVEV | 706 | P23468 | |
| PSGPPRKVEVEAVNS | 711 | P23468 | |
| QPEPLPATAGVKRES | 706 | Q9P2E2 | |
| PTEPGPQSASEVEKI | 396 | Q9NZT2 | |
| KEPTKVASGRTTPAP | 716 | Q8NEY1 | |
| PDVSEEAPGPSKVKT | 211 | Q9BY42 | |
| LVKRPVEPQAGAEPS | 171 | Q9H611 | |
| PAAEQPTSIGRIKPE | 196 | Q5T7P8 | |
| VEDTPSDIPTPTIRG | 3106 | O75445 | |
| RARTKEDVPQGVSPP | 3491 | O75445 | |
| EKTRPEGEPSSLSPE | 111 | Q9BRT9 | |
| RSQEPTVGPPEKTEE | 336 | P32745 | |
| VSDIRPGSDPTKPDA | 821 | Q06033 | |
| PGSDPTKPDATLVVK | 826 | Q06033 | |
| ELEKAEGPSARPATP | 586 | O14594 | |
| EEPVPNSIGKSPDSV | 391 | O00141 | |
| EDVPRPPDTVSTGKG | 56 | Q96PZ0 | |
| NKIVSLDPSEAGPPR | 76 | Q13291 | |
| PTAPATDAAPKRVEI | 176 | Q9UHD8 | |
| SAKVPTAEPPGEVAV | 21 | Q13203 | |
| RSPPIPLAKVDATAE | 226 | P13667 | |
| ERPLAASPPGTVKAE | 1511 | O95785 | |
| RKETAPVQLPVSGPE | 576 | Q9BVR0 | |
| PVPPTTVRTDSLGKD | 451 | Q68BL8 | |
| ASINPVTGRVEEKPP | 451 | Q9NPQ8 | |
| TSSKPRGPVLPQELE | 386 | Q8TCX5 | |
| SPRVLPVPSEAVGKE | 131 | Q9BR10 | |
| EKRLLGENSVPPSPS | 246 | Q3YBM2 | |
| DGPSPPDTRVGSREK | 971 | Q9Y566 | |
| LSVRAKPSAPVVSGP | 141 | Q5TFQ8 | |
| SRSRVPEKPASGPTE | 696 | Q8WYL5 | |
| GVKTEVEDTLTPPPS | 416 | P36956 | |
| KPAASDLPVPAEGVR | 696 | Q05682 | |
| QPLIRTEAPESKPGS | 251 | Q13286 | |
| LEKASSRPGSPTADP | 386 | Q96LI5 | |
| PRPSAKPSVVAEVKG | 871 | O94762 | |
| LSVRAKPSAPVVSGP | 141 | O00241 | |
| KPSAPVVSGPAVRAT | 146 | O00241 | |
| DTPGLEVPSSPLRKA | 386 | Q86WB0 | |
| PVKSETSPVAPRAGS | 1016 | Q9Y4G8 | |
| PTPGITRKEEAPENV | 1041 | O15417 | |
| SPSKITEPLREGPEE | 1136 | O15417 | |
| SEIIESVPPAGPEAS | 6 | Q9Y4E5 | |
| KDPATVDVSGTGRPS | 186 | Q5W0Q7 | |
| ALGDSTKPETVEPIP | 51 | Q14592 | |
| PTEPLGDKVSSERKP | 2301 | Q9C0A1 | |
| SIASTPPGEDRKSPR | 146 | Q8IVF5 | |
| TVAVARVPGKLAPPE | 2671 | Q15772 | |
| PSPVKPASLERVEGL | 1576 | Q9BYB0 | |
| EVKVVSPAPTAQPRD | 1216 | O95428 | |
| PKASDEVPLAPRTEA | 86 | Q8TB61 | |
| SLDPEAAIGVTKRPP | 61 | O14662 | |
| EASPPAQGIPEAKVR | 246 | Q9H7M9 | |
| PPNKPRLGELTVTDA | 2841 | P22105 | |
| PVPVEARTAPDTKPS | 3341 | P22105 | |
| KAAVESPVPKPSEAR | 241 | Q8N9M5 | |
| LGSKEPRPSVHVPVS | 1201 | O15014 | |
| LSRPPESELEVAPKG | 1051 | Q5T1R4 | |
| DVPVSKFDGSPREIP | 356 | Q3MJ13 | |
| PSGPSAPEAVTARLV | 6 | Q9BX74 | |
| VPTLEVPAPEAVSSG | 381 | Q86V40 | |
| TSAPVTLVAPGEARP | 46 | Q4KMP7 | |
| DEEPTTLPSGEAKPR | 306 | Q9Y4E1 | |
| ADTPKSGEPRVPEEA | 311 | P13994 | |
| GLSPTTRTDPDDPKI | 701 | Q8TE23 | |
| DLPDPSPGTTVAVVD | 1001 | Q8IUG5 | |
| TATPRKLPEGESAPL | 256 | Q96C00 | |
| DEEPTTLPSGEAKPR | 306 | Q641Q2 | |
| RPTPASPALEEKEGE | 301 | Q13061 | |
| DKGSLPQPPITEVES | 201 | Q9UNY5 | |
| TPTLPKQDRPVREGT | 886 | Q9UPP1 | |
| LAPETTSPGDRVETP | 211 | Q8TD55 | |
| PQPLVEKSELAPTRG | 1656 | Q9Y3S1 | |
| VTSEPSRPEPAVFKA | 141 | Q16762 | |
| PPRTKPERTTSAGTI | 471 | Q7Z7G0 | |
| GEETPLSVPPVDSTI | 601 | O15016 | |
| TEPVEPLTRASSAGP | 371 | A4D1P6 | |
| PVAVRSKVPDSEFPV | 1586 | P01266 | |
| RKDTVPRPASPTEAG | 1836 | P01266 | |
| GQSRTPRISPPIKEE | 401 | Q6PJT7 | |
| PEKIKGSTPRNDPSV | 426 | Q63HR2 | |
| EVSPEVVRSKLSPSP | 196 | Q5T200 | |
| IPGPSTEPSVVESKD | 1066 | O95071 | |
| QVSEDVRSPAGPKVP | 181 | P07101 | |
| AVRLEVTDGPPATPA | 151 | Q9BRK3 | |
| SPKKAPATPVTREGA | 1411 | E9PAV3 | |
| PATPVTREGAATPSK | 1416 | E9PAV3 | |
| SEETEKTLPSGSPRP | 1231 | Q13459 | |
| IVPGPPTDLSVTEAT | 636 | P52179 | |
| GEEALKTPPVEAPSR | 301 | Q8NFW9 | |
| SAQKAPELRGPESPS | 321 | Q01538 |